← Evidence map

TrialLeukemia2026

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat.

Valeria Santini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41526614